Switch theme
Sign up to access all valuation multiples
Infinitt Healthcare Co Ltd is a Korea based company engaged in developing digital solutions used in hospitals. It offers clinical solutions, enterprise imaging solutions and radiology solutions. Clinical solutions cover cardiology PACS, digital pathology solutions, 3D solution, 3D printing service, radiation oncology information solution and others. Radiology solutions include PACS, RIS, Data Analytics solution, Cloud PACS, TeleRadiology solution and others.
2002
n/a
Last FY Revenue $73.8M
Last FY EBITDA $41.4M
$2.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Infinitt Healthcare achieved revenue of $73.8M and an EBITDA of $41.4M.
Infinitt Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Infinitt Healthcare valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $73.8M | XXX | XXX | XXX |
| Gross Profit | XXX | $47.2M | XXX | XXX | XXX |
| Gross Margin | XXX | 64% | XXX | XXX | XXX |
| EBITDA | XXX | $41.4M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 56% | XXX | XXX | XXX |
| EBIT | XXX | $10.1M | XXX | XXX | XXX |
| EBIT Margin | XXX | 14% | XXX | XXX | XXX |
| Net Profit | XXX | $31.9M | XXX | XXX | XXX |
| Net Margin | XXX | 43% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Infinitt Healthcare's stock price is KRW 6290 (or $5).
Infinitt Healthcare has current market cap of KRW 153B (or $111M), and EV of KRW 3.2B (or $2.4M).
See Infinitt Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.4M | $111M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Infinitt Healthcare has market cap of $111M and EV of $2.4M.
Infinitt Healthcare's trades at 0.0x EV/Revenue multiple, and 0.1x EV/EBITDA.
Equity research analysts estimate Infinitt Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Infinitt Healthcare's P/E ratio is not available.
See valuation multiples for Infinitt Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $111M | XXX | $111M | XXX | XXX | XXX |
| EV (current) | $2.4M | XXX | $2.4M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 0.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 3.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 0.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialInfinitt Healthcare's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Infinitt Healthcare's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Infinitt Healthcare's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Infinitt Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 56% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 50% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Infinitt Healthcare acquired XXX companies to date.
Last acquisition by Infinitt Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Infinitt Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Infinitt Healthcare founded? | Infinitt Healthcare was founded in 2002. |
| Where is Infinitt Healthcare headquartered? | Infinitt Healthcare is headquartered in South Korea. |
| Is Infinitt Healthcare publicy listed? | Yes, Infinitt Healthcare is a public company listed on KRX. |
| What is the stock symbol of Infinitt Healthcare? | Infinitt Healthcare trades under 071200 ticker. |
| When did Infinitt Healthcare go public? | Infinitt Healthcare went public in 2010. |
| Who are competitors of Infinitt Healthcare? | Similar companies to Infinitt Healthcare include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Infinitt Healthcare? | Infinitt Healthcare's current market cap is $111M |
| Is Infinitt Healthcare profitable? | Yes, Infinitt Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
